MENU
+Compare
DGX
Stock ticker: NYSE
AS OF
Feb 21, 04:15 PM (EDT)
Price
$172.13
Change
-$0.01 (-0.01%)
Capitalization
14.74B

DGX stock forecast, quote, news & analysis

DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for DGX with price predictions
Feb 20, 2025

DGX in upward trend: 10-day moving average moved above 50-day moving average on January 31, 2025

The 10-day moving average for DGX crossed bullishly above the 50-day moving average on January 31, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 24, 2025. You may want to consider a long position or call options on DGX as a result. In of 76 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

DGX moved above its 50-day moving average on January 27, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where DGX advanced for three days, in of 334 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 289 cases where DGX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 17 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DGX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DGX broke above its upper Bollinger Band on February 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.366) is normal, around the industry mean (23.448). P/E Ratio (17.993) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (1.597) is also within normal values, averaging (5.667). Dividend Yield (0.021) settles around the average of (0.018) among similar stocks. P/S Ratio (1.646) is also within normal values, averaging (41.230).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. DGX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
published Dividends

DGX paid dividends on January 29, 2025

Quest Diagnostics DGX Stock Dividends
А dividend of $0.75 per share was paid with a record date of January 29, 2025, and an ex-dividend date of January 14, 2025. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Intuitive Surgical (NASDAQ:ISRG), Medtronic plc (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Align Technology (NASDAQ:ALGN), Illumina (NASDAQ:ILMN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 8.17B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. PRPH experienced the highest price growth at 74%, while IBXXF experienced the biggest fall at -71%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -22%. For the same stocks of the Industry, the average monthly volume growth was 7% and the average quarterly volume growth was 47%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 72
Price Growth Rating: 58
SMR Rating: 84
Profit Risk Rating: 88
Seasonality Score: -40 (-100 ... +100)
View a ticker or compare two or three
DGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a provider of diagnostic testing and information services

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Servicestothe Health Industry
Address
500 Plaza Drive
Phone
+1 973 520-2700
Employees
48000
Web
https://www.questdiagnostics.com